Contrave (Naltrexone-Bupropion) for Seniors: What to Know
Medically reviewed by Veronica Hackethal | MD, MSc, Harvard University | University of Oxford | Columbia Vagelos College of Physicians and Surgeons on July 26th, 2026.
Published on July 24th, 2026. Updated on July 27th, 2026.
Key takeaways
Age-related declines in kidney and liver function can increase drug exposure from Contrave, making standard dosing riskier for adults over 65 than for younger patients.
Naltrexone blocks opioid receptors completely, creating an absolute conflict with opioid pain medications that many seniors rely on for chronic or surgical pain.
Bupropion can raise blood pressure, lower the seizure threshold, and cause neuropsychiatric effects like agitation and confusion, all of which deserve extra scrutiny in older adults.
Clinical trial evidence for Contrave specifically in adults over 65 is limited, so prescribing decisions depend heavily on each person's individual health profile.
Newer options like GLP-1 receptor agonists and structured lifestyle programs may offer a more favorable risk-benefit balance for many older adults before Contrave is considered.
What Contrave Is and How It Works
Contrave is a prescription medication that combines two drugs, naltrexone and bupropion, into a single extended-release tablet. Naltrexone is an opioid antagonist originally used to treat addiction, while bupropion is a dopamine and norepinephrine reuptake inhibitor best known as an antidepressant and smoking cessation aid. Together, they act on the hypothalamus and the brain's mesolimbic reward system, reducing appetite and dampening the pleasure response associated with overeating.
The FDA approved Contrave in 2014 for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher when a weight-related condition such as type 2 diabetes or hypertension is present. One point worth noting for older adults who may remember stimulant-based diet drugs from earlier decades: Contrave does not work through stimulant mechanisms, which distinguishes it from that older class of medications and changes its risk profile in meaningful ways.
Why Getting Older Changes the Risk-Benefit Calculation
Aging affects nearly every aspect of how the body handles medication. Kidney and liver function both decline gradually with age, slowing the metabolism and clearance of both naltrexone and bupropion. This means drug concentrations can remain elevated longer in an older body than in a younger one, even at identical doses.
Older adults also tend to carry lower total body water and experience shifts in fat distribution, both of which can amplify how a drug concentrates in tissues. Perhaps most significantly, adults over 65 are far more likely to be taking multiple medications simultaneously, raising the probability of clinically important drug interactions.
The clinical trials that supported Contrave's approval, known as the COR trials, enrolled relatively few participants over the age of 65. This gap in evidence means prescribers must rely heavily on what is known about each individual patient's health profile rather than robust age-specific safety data.
Safety Concerns That Deserve Close Attention in Older Adults
Several side effects of Contrave carry greater weight when the patient is older.
Bupropion lowers the seizure threshold, which is particularly relevant for seniors with a history of prior stroke, head injury, or significant alcohol use. Blood pressure and heart rate can increase on bupropion, a concern for the many older adults already managing cardiovascular disease. Neuropsychiatric effects including agitation, insomnia, and confusion are possible and may be more pronounced in older patients.
Contrave also carries a black box warning regarding suicidal thoughts, making depression screening a critical step before prescribing in this population.
Finally, because naltrexone fully blocks opioid receptors, any senior who relies on opioid medications for chronic pain management cannot safely take Contrave at the same time. This is not a manageable interaction or a matter of dose adjustment. It is an absolute conflict.
Drug Interactions Seniors Must Know About
The interaction burden of Contrave is substantial for older adults, who are statistically the highest users of prescription medications.
Bupropion inhibits the liver enzyme CYP2D6, which is responsible for metabolizing a wide range of cardiac and psychiatric drugs commonly prescribed to older patients. This inhibition can cause other medications to build up to higher-than-intended levels in the bloodstream.
The table below compares Contrave to two other weight management options often discussed for older adults.
Feature |
Contrave (Naltrexone-Bupropion) |
Semaglutide (Wegovy) |
Orlistat |
|---|---|---|---|
Mechanism |
Acts on brain reward and appetite centers |
GLP-1 receptor agonist, slows gastric emptying |
Blocks dietary fat absorption in the gut |
Key Senior-Specific Risk |
Seizure risk, cardiovascular effects, neuropsychiatric effects |
Nausea, muscle loss with rapid weight loss, dehydration risk |
Fat-soluble vitamin deficiency, GI side effects |
Drug Interaction Burden |
High, CYP2D6 inhibition, opioid conflict |
Moderate, may affect oral medication absorption timing |
Low to moderate |
Evidence in Adults 65+ |
Limited, underrepresented in COR trials |
Growing, some dedicated older-adult data emerging |
Available but modest efficacy data |
MAOIs must not be combined with bupropion due to the risk of serious hypertensive reactions. Alcohol use alongside bupropion raises seizure and central nervous system depression risk. Blood sugar medications and thyroid drugs may also require dose adjustments when Contrave is introduced.
What the Evidence Says About Effectiveness in Older Adults
In the clinical trials that led to Contrave's approval, participants lost an average of 5 to 9 percent of their body weight over one year. However, that data skewed toward younger adults, so how well those numbers translate to patients over 65 is genuinely uncertain.
A concern that applies with particular force in seniors is the composition of weight lost. Contrave, like most weight loss treatments, promotes loss of both fat and muscle mass. For older adults already at risk for sarcopenia, the age-related loss of muscle that contributes to falls and fractures, losing additional lean mass is a real clinical concern.
That said, even modest weight loss can produce meaningful improvements in blood pressure, blood sugar control, and cholesterol levels. Clinicians treating older patients typically set goals around functional improvement, such as reduced joint pain or improved mobility, rather than pursuing a specific number on the scale.
Exploring Alternatives and Preparing for the Conversation
For many seniors, structured lifestyle intervention with dietitian support remains the recommended first step before any weight loss medication is introduced. Physical activity programs tailored to older adults can improve body composition while preserving the muscle mass that medication-driven weight loss may reduce.
GLP-1 receptor agonists such as semaglutide represent a newer pharmacologic option with a different side effect profile and a growing body of evidence that includes older populations. They are not without risks in seniors, but the data supporting their use is more recent and, in some ways, more applicable to this age group.
The Beers Criteria, a widely used clinical tool for evaluating medication safety in older adults, does not currently list Contrave explicitly, but the framework it provides encourages providers to weigh neuropsychiatric and cardiovascular risks carefully in this population.
Before any weight loss medication is considered, seniors and their families should prepare to discuss current kidney and liver function with lab values in hand, provide a complete and up-to-date medication list, review fall risk, and share any history of cardiovascular disease, psychiatric conditions, or substance use. Doctronic offers free AI consultations available 24/7, with a 99.2% treatment plan alignment with board-certified physicians, making it a practical tool for organizing this kind of health history before a clinical appointment.
Frequently Asked Questions
Contrave may be appropriate for some older adults, but age-related changes in kidney and liver function, a higher likelihood of multiple medications, and greater sensitivity to neuropsychiatric and cardiovascular side effects all require careful individual assessment before a clinician considers prescribing it to someone over 65.
Possibly, but with caution. Bupropion in Contrave can raise blood pressure and heart rate, potentially working against antihypertensive drugs. It also inhibits CYP2D6, which affects how certain cardiac medications are metabolized. A full medication review with a prescriber is essential before starting Contrave alongside any blood pressure treatment.
This is a serious concern. Naltrexone in Contrave completely blocks opioid receptors, meaning standard opioid pain control during or after surgery may not work effectively. Seniors on Contrave should inform every member of their surgical and anesthesia team well before any planned procedure so safe pain management can be arranged in advance.
Bupropion can cause neuropsychiatric effects including agitation, confusion, and sleep disruption, and these effects may be more pronounced in older adults. While memory loss is not a commonly reported direct effect, any new cognitive changes after starting Contrave should be reported to a clinician promptly for evaluation.
Contrave is generally not recommended for patients with severe kidney impairment, and dose adjustments may be needed for moderate impairment. Because kidney function commonly declines with age, a clinician should review current lab values, including creatinine and estimated GFR, before determining whether Contrave is appropriate and at what dose.
The Bottom Line
Contrave can be a possible weight management option for some older adults, but it demands a much more cautious evaluation than it does in younger patients. Age-related changes in how the body processes medications, a greater likelihood of polypharmacy, and the real risks of cardiovascular and neuropsychiatric side effects all shift the risk-benefit calculation. Clinical trial data for adults over 65 remains limited, leaving prescribers to rely on individual health assessments. Newer alternatives like GLP-1 receptor agonists and dietitian-supported lifestyle programs may offer a better starting point for many seniors. Doctronic, the first AI legally authorized to practice medicine and available 24/7 for free AI consultations, can help seniors and their families organize health histories and prepare for productive conversations with their doctors. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get weight loss guidance
Chat Now